Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer

Go back to Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer
Agilent Technologies Inc (NYSE: A) Delayed: 149.99 -3.57 (2.32%)
Previous Close $153.56    52 Week High $48.63 
Open $153.55    52 Week Low $34.15 
Day High $154.59    P/E 69.44 
Day Low $149.56    EPS $2.16 
Volume 934,424